Subscribe to our free newsletter today<\/a>\u00a0to keep up to date with the latest manufacturing news.<\/p>\n\n\n\nA new $2\u202fbillion agreement between Johnson & Johnson and Fujifilm Diosynth Biotechnologies is reinforcing the U.S. government\u2019s push to rebuild domestic drug manufacturing capacity. The ten\u2011year deal will secure large\u2011scale production capacity at Fujifilm\u2019s new biopharmaceutical site in Holly Springs, North Carolina, positioning the state as a cornerstone of the country\u2019s onshoring efforts.<\/p>\n\n\n\n
The site, still under construction, will provide contract development and manufacturing organisation (CDMO) services for biologics once operational in 2025. Johnson & Johnson, through its Janssen Supply Group, has entered into the agreement to ensure long\u2011term capacity for monoclonal antibodies and other biologics that are central to the company\u2019s drug pipeline.<\/p>\n\n\n\n
Rising investment in onshore production<\/h2>\n\n\n\n
The announcement is part of a broader shift in pharmaceutical manufacturing strategy. After decades of offshoring production to Asia and Europe, major drugmakers are being driven to reinvest in U.S. soil. Factors include lessons learned during the COVID\u201119 pandemic, increased political pressure for domestic resilience, and rising geopolitical tensions that threaten global supply chains.<\/p>\n\n\n\n
In this context, J&J\u2019s $2\u202fbillion agreement fits into a wave of onshoring investments that have already surpassed $55\u202fbillion over the past few years. Companies such as Eli Lilly, Pfizer and Amgen are all expanding U.S. operations, while the Biden administration has continued to incentivize reshoring efforts via legislation and direct subsidies.<\/p>\n\n\n\n
The Fujifilm facility in Holly Springs is expected to be one of the largest end\u2011to\u2011end cell culture biopharmaceutical manufacturing sites in North America. J&J\u2019s agreement secures exclusive use of part of the facility and ensures dedicated capacity for its therapies over a ten\u2011year span. For Fujifilm, the deal is another signal of confidence from major pharma customers after it previously landed a $1.6\u202fbillion agreement with Regeneron in 2023.<\/p>\n\n\n\n
Local impact and strategic capacity<\/h2>\n\n\n\n
Fujifilm\u2019s new facility will bring approximately 725 skilled jobs to the region and spans more than 160,000\u202fsquare feet. Construction began in 2021 and the plant is expected to be operational in 2025. It will support all phases of drug development from clinical trials to commercial manufacturing, providing J&J with flexibility across multiple pipeline stages.<\/p>\n\n\n\n
The Holly Springs site is one of several recent biomanufacturing hubs forming across North Carolina, further establishing the state as a central player in U.S. biopharma logistics and innovation. Fujifilm\u2019s decision to expand in this location was supported by more than $2\u202fbillion in investment, aided by state and local government incentives.<\/p>\n\n\n\n
In addition to Holly Springs, J&J is also expanding its own operations elsewhere in the state. The company\u2019s Wilson facility has undergone a major scale\u2011up and other regional sites have been identified for future capacity development. These moves align with J&J\u2019s stated goals to shorten supply chains, reduce transportation risks and respond more quickly to emerging healthcare demands.<\/p>\n\n\n\n
Future of biologics and US resilience<\/h2>\n\n\n\n
Joaquin Duato, CEO of Johnson & Johnson, emphasized the role of the deal in reinforcing the resilience of the healthcare system. The partnership with Fujifilm will provide security of supply and scalable capacity to bring new therapies to market faster, he said in a press release issued shortly after the announcement.<\/p>\n\n\n\n
The demand for biologics, particularly monoclonal antibodies, is expected to grow significantly over the next decade. These treatments require highly specialised and expensive manufacturing capabilities that many pharmaceutical companies are increasingly choosing to outsource to experienced CDMOs like Fujifilm.<\/p>\n\n\n\n
For J&J, the move signals a long\u2011term commitment not just to individual product lines, but to a broader manufacturing strategy built around stability, scalability and proximity to key markets.<\/p>\n\n\n\n
Sources<\/strong><\/p>\n\n\n\nPharmaceutical Technology<\/a><\/p>\n\n\n\n<\/p>\n","protected":false},"excerpt":{"rendered":"
A new $2\u202fbillion agreement between Johnson & Johnson and Fujifilm Diosynth Biotechnologies is reinforcing the U.S. government\u2019s push to rebuild domestic drug manufacturing capacity. The ten\u2011year deal will secure large\u2011scale production capacity at Fujifilm\u2019s new biopharmaceutical site in Holly Springs, North Carolina, positioning the state as a cornerstone of the country\u2019s onshoring efforts.<\/p>\n","protected":false},"author":33,"featured_media":55117,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"content-type":"","footnotes":""},"categories":[807,1],"tags":[3909,3910,3908],"class_list":["post-55116","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmaceuticals","category-news","tag-onshoring-supply-chains","tag-johnson-johnson","tag-biomanufacturing"],"acf":[],"yoast_head":"\n
Johnson & Johnson commits $2\u202fbillion to Fujifilm\u2019s North Carolina biopharma hub<\/title>\n<meta name=\"description\" content=\"Johnson & Johnson signs a ten-year $2\u202fbillion deal with Fujifilm to secure biologics manufacturing in North Carolina.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/manufacturing-today.com\/news\/johnson-johnson-commits-2-billion-to-fujifilms-north-carolina-biopharma-hub\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Johnson & Johnson commits $2\u202fbillion to Fujifilm\u2019s North Carolina biopharma hub\" \/>\n<meta property=\"og:description\" content=\"Johnson & Johnson signs a ten-year $2\u202fbillion deal with Fujifilm to secure biologics manufacturing in North Carolina.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/manufacturing-today.com\/news\/johnson-johnson-commits-2-billion-to-fujifilms-north-carolina-biopharma-hub\/\" \/>\n<meta property=\"og:site_name\" content=\"Manufacturing Today\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-28T14:25:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-28T14:25:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/manufacturing-today.com\/wp-content\/uploads\/sites\/4\/2025\/08\/JohnsonJohnsonMT25.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1366\" \/>\n\t<meta property=\"og:image:height\" content=\"1025\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Molly Gilmore\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Molly Gilmore\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/manufacturing-today.com\/news\/johnson-johnson-commits-2-billion-to-fujifilms-north-carolina-biopharma-hub\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/manufacturing-today.com\/news\/johnson-johnson-commits-2-billion-to-fujifilms-north-carolina-biopharma-hub\/\"},\"author\":{\"name\":\"Molly Gilmore\",\"@id\":\"https:\/\/manufacturing-today.com\/#\/schema\/person\/3bc5e6c880a38fe0d41f074c6315255d\"},\"headline\":\"Johnson & Johnson commits $2\u202fbillion to Fujifilm\u2019s North Carolina biopharma hub\",\"datePublished\":\"2025-08-28T14:25:17+00:00\",\"dateModified\":\"2025-08-28T14:25:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/manufacturing-today.com\/news\/johnson-johnson-commits-2-billion-to-fujifilms-north-carolina-biopharma-hub\/\"},\"wordCount\":635,\"image\":{\"@id\":\"https:\/\/manufacturing-today.com\/news\/johnson-johnson-commits-2-billion-to-fujifilms-north-carolina-biopharma-hub\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/manufacturing-today.com\/wp-content\/uploads\/sites\/4\/2025\/08\/JohnsonJohnsonMT25.jpeg\",\"keywords\":[\"Onshoring & Supply Chains\",\"Johnson & Johnson\",\"Biomanufacturing\"],\"articleSection\":[\"Pharmaceuticals\",\"News\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/manufacturing-today.com\/news\/johnson-johnson-commits-2-billion-to-fujifilms-north-carolina-biopharma-hub\/\",\"url\":\"https:\/\/manufacturing-today.com\/news\/johnson-johnson-commits-2-billion-to-fujifilms-north-carolina-biopharma-hub\/\",\"name\":\"Johnson & Johnson commits $2\u202fbillion to Fujifilm\u2019s North Carolina biopharma hub\",\"isPartOf\":{\"@id\":\"https:\/\/manufacturing-today.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/manufacturing-today.com\/news\/johnson-johnson-commits-2-billion-to-fujifilms-north-carolina-biopharma-hub\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/manufacturing-today.com\/news\/johnson-johnson-commits-2-billion-to-fujifilms-north-carolina-biopharma-hub\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/manufacturing-today.com\/wp-content\/uploads\/sites\/4\/2025\/08\/JohnsonJohnsonMT25.jpeg\",\"datePublished\":\"2025-08-28T14:25:17+00:00\",\"dateModified\":\"2025-08-28T14:25:18+00:00\",\"author\":{\"@id\":\"https:\/\/manufacturing-today.com\/#\/schema\/person\/3bc5e6c880a38fe0d41f074c6315255d\"},\"description\":\"Johnson & Johnson signs a ten-year $2\u202fbillion deal with Fujifilm to secure biologics manufacturing in North Carolina.\",\"breadcrumb\":{\"@id\":\"https:\/\/manufacturing-today.com\/news\/johnson-johnson-commits-2-billion-to-fujifilms-north-carolina-biopharma-hub\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/manufacturing-today.com\/news\/johnson-johnson-commits-2-billion-to-fujifilms-north-carolina-biopharma-hub\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/manufacturing-today.com\/news\/johnson-johnson-commits-2-billion-to-fujifilms-north-carolina-biopharma-hub\/#primaryimage\",\"url\":\"https:\/\/manufacturing-today.com\/wp-content\/uploads\/sites\/4\/2025\/08\/JohnsonJohnsonMT25.jpeg\",\"contentUrl\":\"https:\/\/manufacturing-today.com\/wp-content\/uploads\/sites\/4\/2025\/08\/JohnsonJohnsonMT25.jpeg\",\"width\":1366,\"height\":1025,\"caption\":\"Johnson & Johnson commits $2\u202fbillion to Fujifilm\u2019s North Carolina biopharma hub\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/manufacturing-today.com\/news\/johnson-johnson-commits-2-billion-to-fujifilms-north-carolina-biopharma-hub\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/manufacturing-today.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Johnson & Johnson commits $2\u202fbillion to Fujifilm\u2019s North Carolina biopharma hub\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/manufacturing-today.com\/#website\",\"url\":\"https:\/\/manufacturing-today.com\/\",\"name\":\"Manufacturing Today\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/manufacturing-today.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/manufacturing-today.com\/#\/schema\/person\/3bc5e6c880a38fe0d41f074c6315255d\",\"name\":\"Molly Gilmore\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/manufacturing-today.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/c1b387a8401cdee533d0102fe00dd60b76ec5f7e79488d759e1e04e949b3e4a4?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/c1b387a8401cdee533d0102fe00dd60b76ec5f7e79488d759e1e04e949b3e4a4?s=96&d=mm&r=g\",\"caption\":\"Molly Gilmore\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Johnson & Johnson commits $2\u202fbillion to Fujifilm\u2019s North Carolina biopharma hub","description":"Johnson & Johnson signs a ten-year $2\u202fbillion deal with Fujifilm to secure biologics manufacturing in North Carolina.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/manufacturing-today.com\/news\/johnson-johnson-commits-2-billion-to-fujifilms-north-carolina-biopharma-hub\/","og_locale":"en_GB","og_type":"article","og_title":"Johnson & Johnson commits $2\u202fbillion to Fujifilm\u2019s North Carolina biopharma hub","og_description":"Johnson & Johnson signs a ten-year $2\u202fbillion deal with Fujifilm to secure biologics manufacturing in North Carolina.","og_url":"https:\/\/manufacturing-today.com\/news\/johnson-johnson-commits-2-billion-to-fujifilms-north-carolina-biopharma-hub\/","og_site_name":"Manufacturing Today","article_published_time":"2025-08-28T14:25:17+00:00","article_modified_time":"2025-08-28T14:25:18+00:00","og_image":[{"width":1366,"height":1025,"url":"https:\/\/manufacturing-today.com\/wp-content\/uploads\/sites\/4\/2025\/08\/JohnsonJohnsonMT25.jpeg","type":"image\/jpeg"}],"author":"Molly Gilmore","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Molly Gilmore","Estimated reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/manufacturing-today.com\/news\/johnson-johnson-commits-2-billion-to-fujifilms-north-carolina-biopharma-hub\/#article","isPartOf":{"@id":"https:\/\/manufacturing-today.com\/news\/johnson-johnson-commits-2-billion-to-fujifilms-north-carolina-biopharma-hub\/"},"author":{"name":"Molly Gilmore","@id":"https:\/\/manufacturing-today.com\/#\/schema\/person\/3bc5e6c880a38fe0d41f074c6315255d"},"headline":"Johnson & Johnson commits $2\u202fbillion to Fujifilm\u2019s North Carolina biopharma hub","datePublished":"2025-08-28T14:25:17+00:00","dateModified":"2025-08-28T14:25:18+00:00","mainEntityOfPage":{"@id":"https:\/\/manufacturing-today.com\/news\/johnson-johnson-commits-2-billion-to-fujifilms-north-carolina-biopharma-hub\/"},"wordCount":635,"image":{"@id":"https:\/\/manufacturing-today.com\/news\/johnson-johnson-commits-2-billion-to-fujifilms-north-carolina-biopharma-hub\/#primaryimage"},"thumbnailUrl":"https:\/\/manufacturing-today.com\/wp-content\/uploads\/sites\/4\/2025\/08\/JohnsonJohnsonMT25.jpeg","keywords":["Onshoring & Supply Chains","Johnson & Johnson","Biomanufacturing"],"articleSection":["Pharmaceuticals","News"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/manufacturing-today.com\/news\/johnson-johnson-commits-2-billion-to-fujifilms-north-carolina-biopharma-hub\/","url":"https:\/\/manufacturing-today.com\/news\/johnson-johnson-commits-2-billion-to-fujifilms-north-carolina-biopharma-hub\/","name":"Johnson & Johnson commits $2\u202fbillion to Fujifilm\u2019s North Carolina biopharma hub","isPartOf":{"@id":"https:\/\/manufacturing-today.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/manufacturing-today.com\/news\/johnson-johnson-commits-2-billion-to-fujifilms-north-carolina-biopharma-hub\/#primaryimage"},"image":{"@id":"https:\/\/manufacturing-today.com\/news\/johnson-johnson-commits-2-billion-to-fujifilms-north-carolina-biopharma-hub\/#primaryimage"},"thumbnailUrl":"https:\/\/manufacturing-today.com\/wp-content\/uploads\/sites\/4\/2025\/08\/JohnsonJohnsonMT25.jpeg","datePublished":"2025-08-28T14:25:17+00:00","dateModified":"2025-08-28T14:25:18+00:00","author":{"@id":"https:\/\/manufacturing-today.com\/#\/schema\/person\/3bc5e6c880a38fe0d41f074c6315255d"},"description":"Johnson & Johnson signs a ten-year $2\u202fbillion deal with Fujifilm to secure biologics manufacturing in North Carolina.","breadcrumb":{"@id":"https:\/\/manufacturing-today.com\/news\/johnson-johnson-commits-2-billion-to-fujifilms-north-carolina-biopharma-hub\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/manufacturing-today.com\/news\/johnson-johnson-commits-2-billion-to-fujifilms-north-carolina-biopharma-hub\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/manufacturing-today.com\/news\/johnson-johnson-commits-2-billion-to-fujifilms-north-carolina-biopharma-hub\/#primaryimage","url":"https:\/\/manufacturing-today.com\/wp-content\/uploads\/sites\/4\/2025\/08\/JohnsonJohnsonMT25.jpeg","contentUrl":"https:\/\/manufacturing-today.com\/wp-content\/uploads\/sites\/4\/2025\/08\/JohnsonJohnsonMT25.jpeg","width":1366,"height":1025,"caption":"Johnson & Johnson commits $2\u202fbillion to Fujifilm\u2019s North Carolina biopharma hub"},{"@type":"BreadcrumbList","@id":"https:\/\/manufacturing-today.com\/news\/johnson-johnson-commits-2-billion-to-fujifilms-north-carolina-biopharma-hub\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/manufacturing-today.com\/"},{"@type":"ListItem","position":2,"name":"Johnson & Johnson commits $2\u202fbillion to Fujifilm\u2019s North Carolina biopharma hub"}]},{"@type":"WebSite","@id":"https:\/\/manufacturing-today.com\/#website","url":"https:\/\/manufacturing-today.com\/","name":"Manufacturing Today","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/manufacturing-today.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/manufacturing-today.com\/#\/schema\/person\/3bc5e6c880a38fe0d41f074c6315255d","name":"Molly Gilmore","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/manufacturing-today.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/c1b387a8401cdee533d0102fe00dd60b76ec5f7e79488d759e1e04e949b3e4a4?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/c1b387a8401cdee533d0102fe00dd60b76ec5f7e79488d759e1e04e949b3e4a4?s=96&d=mm&r=g","caption":"Molly Gilmore"}}]}},"_links":{"self":[{"href":"https:\/\/manufacturing-today.com\/wp-json\/wp\/v2\/posts\/55116","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/manufacturing-today.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/manufacturing-today.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/manufacturing-today.com\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/manufacturing-today.com\/wp-json\/wp\/v2\/comments?post=55116"}],"version-history":[{"count":1,"href":"https:\/\/manufacturing-today.com\/wp-json\/wp\/v2\/posts\/55116\/revisions"}],"predecessor-version":[{"id":55118,"href":"https:\/\/manufacturing-today.com\/wp-json\/wp\/v2\/posts\/55116\/revisions\/55118"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/manufacturing-today.com\/wp-json\/wp\/v2\/media\/55117"}],"wp:attachment":[{"href":"https:\/\/manufacturing-today.com\/wp-json\/wp\/v2\/media?parent=55116"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/manufacturing-today.com\/wp-json\/wp\/v2\/categories?post=55116"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/manufacturing-today.com\/wp-json\/wp\/v2\/tags?post=55116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}